Osteoporosis is often referred to as the ‘silent disease’ because of its’ asymptomatic nature. Although almost 3 million people in the UK are estimated to have osteoporosis, worryingly few people know they have osteoporosis until they break a bone. There are more than 300,000 fractures every year due to osteoporosis. Osteoporosis has significant impact on healthcare costs and quality of life. Amongst the models for collaborative disease state management services published internationally, there is sparse evidence regarding the role of pharmacists in the provision of osteoporosis care.
This study aims to develop a pharmacist-led osteoporosis disease state management service in the United Kingdom. We will explore stakeholders’ perspective (including the barriers and facilitators) and scope of osteoporosis disease state management services by pharmacists, informing a vision for developing these services. The student will be expected to conduct both qualitative and quantitative analysis.
The project is open to UK/EU and international candidates. Full or partial funding is available. The PhD must be undertaken on a full-time basis. Applicants must be able to demonstrate strong research and analytical skills
The PhD starts in autumn, and will be supervised by Dr Li Shean Toh and Prof Claire Anderson Interested applicants should apply via the online application form